| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.082 | 0.07 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.09 | 0.07 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.07 |